FOSRENOL

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug FOSRENOL contains one active pharmaceutical ingredient (API):

1 Lanthanum carbonate hydrate
UNII 490D9F069T - LANTHANUM CARBONATE

Lanthanum is indicated as a phosphate binding agent for use in the control of hyperphosphataemia.

Read about Lanthanum

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FOSRENOL Chewable tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FOSRENOL Oral powder Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AE03 Lanthanum carbonate V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 5780F, 5781G, 5782H, 9403X, 9404Y, 9405B, 9635D, 9636E, 9637F
Country: CA Health Products and Food Branch Identifier(s): 02287145, 02287153, 02287161, 02287188
Country: EE Ravimiamet Identifier(s): 1234864, 1234875, 1234886, 1234897, 1234910, 1234932, 1234943, 1234954, 1234965, 1235001, 1235012, 1235023, 1235034, 1235045, 1235056, 1235078, 1235089, 1235090, 1235102, 1235113, 1235124, 1517172, 1517183
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 68434, 68438, 68439, 76053, 76054
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 023066, 023080, 023088, 043582, 162294
Country: FR Base de données publique des médicaments Identifier(s): 62429857, 63357492, 63909453, 65651521, 67840531
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 112724, 112727, 112730, 209118, 209121
Country: HK Department of Health Drug Office Identifier(s): 55610
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6489, 6490, 6491, 7954
Country: JP 医薬品医療機器総合機構 Identifier(s): 2190029D1025, 2190029D2021, 2190029F1026, 2190029F2022, 2190029F3029, 2190029F4025
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1022543, 1022544, 1022545, 1026500, 1026503, 1026504, 1026507, 1026510, 1026512, 1026514
Country: NL Z-Index G-Standaard, PRK Identifier(s): 102504, 102512, 80128, 80136, 86843
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 20146, 20147, 20148, 20149, 20150
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100160249, 100160261, 100160278, 100295400, 100295423
Country: SG Health Sciences Authority Identifier(s): 13594P, 13595P, 13596P
Country: US FDA, National Drug Code Identifier(s): 54092-252, 54092-253, 54092-254, 54092-256, 54092-257
Country: ZA Health Products Regulatory Authority Identifier(s): 41/18/0299, 41/18/0300, 41/18/0301, 41/18/0302

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.